Hepatitis C Infection Doubles Risk for Renal Cell Carcinoma
test
Which of the following characteristics best describes the risk for a diagnosis of RCC in patients with chronic HCV infection?
1- Increased in those diagnosed at a younger age
2- Increased in those diagnosed at an older age
3- Increased by almost 3 times
4- Increased in those with papillary RCC only
Which of the following variables is least likely to be an independent predictor of RCC?
1- Chronic kidney disease
2- Female sex
3- African American race
4- Positive HCV infection
A LIRE APRES TEST
April 19, 2010 — Chronic hepatitis C virus (HCV) is a major cause of cirrhosis, liver failure, and hepatocellular carcinoma, but a new study suggests that it is also associated with a higher incidence of renal cell carcinoma (RCC).
Researchers at Henry Ford Hospital in Detroit, Michigan, found that during a 10-year period, patients infected with hepatitis C had nearly double the risk of developing RCC.
The study was published online March 23 in Cancer Epidemiology, Biomarkers & Prevention.
Until now, there have only been anecdotal reports that suggested an association between HCV and an increased risk for kidney cancer, said lead author Stuart C. Gordon, MD, director of hepatology at Henry Ford Hospital. "But this is the first report to evaluate the association in a comprehensive manner," he told Medscape Oncology.
Dr. Gordon explained that he has observed increased rates of RCC in patients infected with HCV in his own practice. Thus, the results of this study were "exciting and reassuring and validated what we had suspected and what we had seen in the literature," he said.
The authors note that patients with chronic HCV infection can manifest extrahepatic complications, such as cryoglobulinemia, vasculitis, and various renal disorders. Infection also confers an increased risk for non-Hodgkin's lymphoma and other hematopoietic malignancies.
HCV has been isolated in kidney glomerular and tubular structures, Dr. Gordon pointed out. "Hepatitis C is a systemic disease, and its impact is not restricted to the liver," he said. "Independent of liver disease, it can also cause kidney disease."
Independent Risk Factor for RCC
The new findings come from a cohort study of administrative data from the large, integrated, and ethnically diverse Henry Ford Hospital. The study consisted of 67,063 patients who were tested for HCV between 1997 and 2006, and who were followed for the development of RCC until April 2008.
Of this population, 3057 (4.6%) patients were HCV-positive, and were older than those who were seronegative (52 vs 48 years; P < .001). Patients with HCV were more likely to have kidney disease than uninfected patients (14.5% vs 10.4%; P < .001) and, as expected, their risk of developing hepatocellular carcinoma was much higher (27.5 of 1000 HCV-positive patients vs 1.4 of 1000 HCV-negative patients).
A diagnosis of RCC was made in 0.6% (17 of 3057) of HCV-positive patients and in 0.3% (177 of 64,006) of HCV-negative patients. The mean age at diagnosis was much younger in those who were HCV-positive (54 vs 63; P < .001). The univariate hazard ratio for RCC among HCV patients was 2.20 (95% confidence interval [CI], 1.32 - 3.67; P = .0025). In a multivariate model that included risk factors such as age, race, sex, and chronic kidney disease, the overall hazard ratio for RCC among HCV patients was 1.77 (95% CI, 1.05 - 2.98; P = .0313).
Kidney cancer is relatively rare, explained Dr. Gordon, and it is premature to recommend more comprehensive screening of HCV-positive patients. "However, physicians should be aware of this relationship," he said, "and patients with RCC may need to be more carefully screened for HCV infection."
"Additional studies are required to confirm these findings and to explore potential mechanisms of oncogenesis," the authors conclude.
No outside agencies or sponsors provided funding for this study. The researchers have disclosed no relevant financial relationships.
Cancer Epidemiol Biomarkers Prev. Published online March 23, 2010. Abstract
Clinical Context
Globally, an estimated 170 million people are infected with chronic HCV, a major cause of liver failure and hepatocellular cancer. HCV is known to confer a higher risk for non-Hodgkin's lymphoma and other malignant diseases. The prevalence of HCV in the United States is 1.6%, and several reports have linked HCV with RCC.
This is a longitudinal cohort study using administrative database information to examine if chronic HCV carries an increased risk for the development of RCC.
Study Highlights
* Chronic HCV infection is associated with a higher risk for diagnosis of RCC at a younger age.
* Independent predictors of RCC include HCV-positive status, older age, African American race, male sex, and chronic kidney disease.
Clinical Implications
* Chronic HCV infection is associated with a higher risk for diagnosis of RCC at a younger age.
* Independent predictors of RCC include HCV-positive status, older age, African American race, male sex, and chronic kidney disease.
REPONSE DU TEST
1.
Which of the following characteristics best describes the risk for a diagnosis of RCC in patients with chronic HCV infection?
Answer: Increased in those diagnosed at a younger age
In HCV-positive patients, the age of diagnosis of RCC was much younger (54 vs 63 years) vs patients with RCC without HCV infection. Researchers found that during a 10-year period, patients infected with HCV had nearly double the risk for the development of RCC. The univariate hazard ratio for RCC among HCV-positive patients was 2.2. There were 17 RCC cases among the HCV-positive cohort, of which 6 were papillary carcinoma and 8 were clear cell carcinoma, with a mean diameter of 3.5 cm.
2.
Which of the following variables is least likely to be an independent predictor of RCC?
Answer: Female sex
In this database cohort study by Gordon and colleagues, HCV-positive status, older age, African American race, male sex, and chronic kidney disease were all independent predictors of RCC.
test
Which of the following characteristics best describes the risk for a diagnosis of RCC in patients with chronic HCV infection?
1- Increased in those diagnosed at a younger age
2- Increased in those diagnosed at an older age
3- Increased by almost 3 times
4- Increased in those with papillary RCC only
Which of the following variables is least likely to be an independent predictor of RCC?
1- Chronic kidney disease
2- Female sex
3- African American race
4- Positive HCV infection
A LIRE APRES TEST
April 19, 2010 — Chronic hepatitis C virus (HCV) is a major cause of cirrhosis, liver failure, and hepatocellular carcinoma, but a new study suggests that it is also associated with a higher incidence of renal cell carcinoma (RCC).
Researchers at Henry Ford Hospital in Detroit, Michigan, found that during a 10-year period, patients infected with hepatitis C had nearly double the risk of developing RCC.
The study was published online March 23 in Cancer Epidemiology, Biomarkers & Prevention.
Until now, there have only been anecdotal reports that suggested an association between HCV and an increased risk for kidney cancer, said lead author Stuart C. Gordon, MD, director of hepatology at Henry Ford Hospital. "But this is the first report to evaluate the association in a comprehensive manner," he told Medscape Oncology.
Dr. Gordon explained that he has observed increased rates of RCC in patients infected with HCV in his own practice. Thus, the results of this study were "exciting and reassuring and validated what we had suspected and what we had seen in the literature," he said.
The authors note that patients with chronic HCV infection can manifest extrahepatic complications, such as cryoglobulinemia, vasculitis, and various renal disorders. Infection also confers an increased risk for non-Hodgkin's lymphoma and other hematopoietic malignancies.
HCV has been isolated in kidney glomerular and tubular structures, Dr. Gordon pointed out. "Hepatitis C is a systemic disease, and its impact is not restricted to the liver," he said. "Independent of liver disease, it can also cause kidney disease."
Independent Risk Factor for RCC
The new findings come from a cohort study of administrative data from the large, integrated, and ethnically diverse Henry Ford Hospital. The study consisted of 67,063 patients who were tested for HCV between 1997 and 2006, and who were followed for the development of RCC until April 2008.
Of this population, 3057 (4.6%) patients were HCV-positive, and were older than those who were seronegative (52 vs 48 years; P < .001). Patients with HCV were more likely to have kidney disease than uninfected patients (14.5% vs 10.4%; P < .001) and, as expected, their risk of developing hepatocellular carcinoma was much higher (27.5 of 1000 HCV-positive patients vs 1.4 of 1000 HCV-negative patients).
A diagnosis of RCC was made in 0.6% (17 of 3057) of HCV-positive patients and in 0.3% (177 of 64,006) of HCV-negative patients. The mean age at diagnosis was much younger in those who were HCV-positive (54 vs 63; P < .001). The univariate hazard ratio for RCC among HCV patients was 2.20 (95% confidence interval [CI], 1.32 - 3.67; P = .0025). In a multivariate model that included risk factors such as age, race, sex, and chronic kidney disease, the overall hazard ratio for RCC among HCV patients was 1.77 (95% CI, 1.05 - 2.98; P = .0313).
Kidney cancer is relatively rare, explained Dr. Gordon, and it is premature to recommend more comprehensive screening of HCV-positive patients. "However, physicians should be aware of this relationship," he said, "and patients with RCC may need to be more carefully screened for HCV infection."
"Additional studies are required to confirm these findings and to explore potential mechanisms of oncogenesis," the authors conclude.
No outside agencies or sponsors provided funding for this study. The researchers have disclosed no relevant financial relationships.
Cancer Epidemiol Biomarkers Prev. Published online March 23, 2010. Abstract
Clinical Context
Globally, an estimated 170 million people are infected with chronic HCV, a major cause of liver failure and hepatocellular cancer. HCV is known to confer a higher risk for non-Hodgkin's lymphoma and other malignant diseases. The prevalence of HCV in the United States is 1.6%, and several reports have linked HCV with RCC.
This is a longitudinal cohort study using administrative database information to examine if chronic HCV carries an increased risk for the development of RCC.
Study Highlights
* Chronic HCV infection is associated with a higher risk for diagnosis of RCC at a younger age.
* Independent predictors of RCC include HCV-positive status, older age, African American race, male sex, and chronic kidney disease.
Clinical Implications
* Chronic HCV infection is associated with a higher risk for diagnosis of RCC at a younger age.
* Independent predictors of RCC include HCV-positive status, older age, African American race, male sex, and chronic kidney disease.
REPONSE DU TEST
1.
Which of the following characteristics best describes the risk for a diagnosis of RCC in patients with chronic HCV infection?
Answer: Increased in those diagnosed at a younger age
In HCV-positive patients, the age of diagnosis of RCC was much younger (54 vs 63 years) vs patients with RCC without HCV infection. Researchers found that during a 10-year period, patients infected with HCV had nearly double the risk for the development of RCC. The univariate hazard ratio for RCC among HCV-positive patients was 2.2. There were 17 RCC cases among the HCV-positive cohort, of which 6 were papillary carcinoma and 8 were clear cell carcinoma, with a mean diameter of 3.5 cm.
2.
Which of the following variables is least likely to be an independent predictor of RCC?
Answer: Female sex
In this database cohort study by Gordon and colleagues, HCV-positive status, older age, African American race, male sex, and chronic kidney disease were all independent predictors of RCC.
Aujourd'hui à 12:53 par pilote
» ATLAS d'Échographie
Aujourd'hui à 00:11 par Baaloudjo
» Pratique de l'échographie obstétricale au 1er trimestre
Hier à 15:02 par toufikflt
» L'échographie pour tous : apprentissage acceléré - de l'échoscopie a l'échographie d'expert
Hier à 14:55 par toufikflt
» les lasers en dermatologie 2018 - exclusif
Hier à 14:00 par mohsif123
» LES OSTÉOTOMIES AUTOUR DU GENOU Cahiers d'Enseignement de la SOFCOT
Hier à 13:54 par mohsif123
» Conférences d'enseignement de la SFOCOT 2019
Hier à 13:52 par mohsif123
» Manuel pratique d'anesthésie Anesthésie
Hier à 02:01 par Baaloudjo
» Collection complète DCEM en questions-réponses
Hier à 01:57 par Baaloudjo
» Télécharger EMC de Pneumologie PDF
Hier à 01:52 par Baaloudjo
» 22/03/2024 Guide d’Échographie Pratique en Anesthésie-Réanimation - GUEPAR (2e édition)
Hier à 01:45 par Baaloudjo
» LE LIVRE NOIR DES ALLERGIES #Allergologie
Hier à 01:44 par Baaloudjo
» Asthme Cas Cliniques #Allergologie
Hier à 01:43 par Baaloudjo
» PHYSIOPATHOLOGIE DE L’ASTHME #Allergologie
Hier à 01:42 par Baaloudjo
» Manuel D'échocardiographie Clinique pdf
Jeu 21 Nov 2024, 10:09 par kazran